Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coxsackievirus A10 (CV-A10) is a non-enveloped, single-stranded RNA virus belonging to the Enterovirus genus within the Picornaviridae family. It is a major causative agent of hand, foot, and mouth disease (HFMD) and can also cause other severe illnesses. CV-A10 enters host cells via the KREMEN1 (KRM1) receptor. There are currently no approved vaccines or specific antiviral drugs for CV-A10 infections.
Viral replication inhibition (potential target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coxsackievirus A10 (CV-A10).